Achieving a high cure rate with direct‐acting antivirals for chronic Hepatitis C virus infection in Cameroon: a multi‐clinic demonstration project-Reference-Cited by-同舟云学术

Achieving a high cure rate with direct‐acting antivirals for chronic Hepatitis C virus infection in Cameroon: a multi‐clinic demonstration project

Published:2020-07-05 Issue:9 Volume:25 Page:1098-1109
ISSN:1360-2276
Container-title:Tropical Medicine & International Health
language:en
Short-container-title:Trop Med Int Health

Author:

Coyer Liza¹,Njoya Oudou²,Njouom Richard³,Mossus Tatiana²,Kowo Mathurin Pierre²,Essomba Frida²,Boers Alexander⁴,Coutinho Roel⁵⁶,Ondoa Pascale⁷⁸,Bilong Catherine,Babagnak Isabelle Dang,Kamto Dyane,Talla Paul,Tchoumi Eric,

Affiliation:

1. Department of Infectious Diseases Public Health Service of Amsterdam Amsterdam The Netherlands

2. Research Laboratory on Viral Hepatitis and Health Communication University of Yaoundé I Yaoundé Cameroon

3. Centre Pasteur du Cameroun Yaoundé Cameroon

4. Joep Lange Institute Amsterdam The Netherlands

5. PharmAccess Foundation Amsterdam The Netherlands

6. Julius Center for Health Sciences and Primary Care University Medical Center Utrecht Utrecht The Netherlands

7. African Society for Laboratory Medicine Addis Ababa Ethiopia

8. Amsterdam Institute for Global Health and Development Amsterdam The Netherlands

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,Parasitology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tmi.13450

Reference46 articles.

1. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013

2. Exploratory Study of Oral Combination Antiviral Therapy for Hepatitis C

3. Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection

4. Progress report on access to hepatitis C treatment:focus on overcoming barriers in low‐ and middle‐income countries March 2018. Geneva Switzerland: World Health Organization; 2018.

5. Global progress on the elimination of viral hepatitis as a major public health threat: An analysis of WHO Member State responses 2017

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A small-scale ‘Development Impact Bond’ for hepatitis C diagnosis and treatment financing in Cameroon: the way to elimination?;Journal of Global Health Reports;2023-12-11

2. A small-scale Development Impact Bond for hepatitis C diagnosis and treatment in Cameroon: the way to elimination?;2023-03-28

3. Patient-reported outcomes with direct-acting antiviral treatment for hepatitis C in West and Central Africa (TAC ANRS 12311 trial);JHEP Reports;2023-03

4. Challenge of managing hepatitis B virus and hepatitis C virus infections in resource-limited settings;World Journal of Hepatology;2022-07-27

5. Safety and efficacy of sofosbuvir–velpatasvir–voxilaprevir for re-treatment of chronic hepatitis C virus infection in patients with previous direct-acting antiviral treatment failure in Rwanda (SHARED-3): a single-arm trial;The Lancet Gastroenterology & Hepatology;2022-06